Search companies on Owler
Advanced Search
Latest news
Newsfeed
My followed companies
Followed Companies

Actelion's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Actelion is a bio-technology firm that discovers, develops and commercializes drugs for unmet medical needs.

Actelion's h... Read more

CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Founded:

1997

Status:

PrivateSubsidiary of Johnson & Johnson

SIC Code:

2834 NAICS listing »

Est. Annual Revenue
Est. Employees
Sector
Pharmaceuticals
Headquarters

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

CEO

- -
2,421
$0
$2.4B
1

Daniel O’Day

Chairman & CEO

68/100
11,000
$86.3M
$22.7B
2

Alexander Hardy

CEO

80/100
13,000
$100M
$18.3B
3

Robert A. Bradway

Chairman & CEO

68/100
19,200
$4B
$24B
4

Kenneth C. Frazier

Chairman & CEO

70/100
69,000
- -
$48.1B
5

Vasant Narasimhan

CEO

61/100
118,393
- -
$48.6B
6

Richard A. Gonzalez

Chairman & CEO

58/100
78
$3.8B
$34.1B
7

Giovanni Caforio

Chairman & CEO

63/100
23,300
- -
$31B
8

Albert Bourla

Chairman & CEO

74/100
92,400
- -
$50.7B
9

Paul Hudson

CEO

80/100
106,859
- -
$41B
10

David A. Ricks

Chairman & CEO

59/100
38,680
- -
$23.1B
The top 10 competitors in Actelion's competitive set are Gilead, Genentech, Amgen, Merck, Novartis, AbbVie, Bristol Myers Squibb, Pfizer, Sanofi and Eli Lilly. Together they have raised over 8.0B between their estimated 505.4K employees. Actelion's revenue is the ranked lowest among it's top 10 competitors. The top 10 competitors average 31.3B. Actelion has 2,421 employees and is ranked 10th among it's top 10 competitors. The top 10 competitors average 44,939.

Gilead is seen as one of Actelion's biggest rivals. Gilead was founded in 1987 in Foster City, California. Like Actelion, Gilead also operates in the Pharmaceuticals sector. Gilead generates $20.3B more revenue than Actelion.

Genentech is one of Actelion's top competitors. Genentech was founded in 1976, and its headquarters is in South San Francisco, California. Like Actelion, Genentech also operates in the Pharmaceuticals space. Genentech has 10,579 more employees than Actelion.

Amgen is one of Actelion's top rivals. Amgen was founded in 1980, and is headquartered in Thousand Oaks, California. Amgen operates in the Biotechnology industry. Amgen generates $21.6B more revenue vs. Actelion.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is AbbVie a competitor of Actelion?

I don't know

Trending News for Actelion and Actelion's Competitors

July 10, 2020

MarketWatch

Gilead says coronavirus drug remdesivir can reduce risk of death, but analysts need more proof

Shares of Gilead Sciences Inc. gained 2.0% on Friday after the drugmaker shared potentially promising... See more »

July 9, 2020

The Center for Biosimilar

Genentech and Amgen Cease Fire on Biosimilar Litigation

In court filings this week, Genentech and Amgen laid to rest their long running dispute over the mark... See more »

July 9, 2020

The Center for Biosimilar

Genentech and Amgen Cease Fire on Biosimilar Litigation

In court filings this week, Genentech and Amgen laid to rest their long running dispute over the mark... See more »

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

-

Sep 2003

Source »
$45.2M
-

These are all the companies that Actelion has acquired. Actelion's latest acquisition was in Sep 2003.

Investments

No recent investments found related to Actelion

Actelion News

January 26, 2020BioPortfolio

Actelion Ltd Strategy SWOT and Corporate Finance Report Published by Marketline Prices from USD $149

Actelion Ltd Strategy SWOT and Corporate Finance ReportSummaryActelion Ltd Strategy SWOT and Corporat... See more »
November 13, 2019The Pharma Letter

Actelion pulls supplemental indication applications for Opsumit

Actelion Pharmaceuticals has decided to voluntarily withdraw the European and other health authority.... See more »
July 26, 2019FinanzNachrichten

Janssen's Late-stage Study On Relapsing Multiple Sclerosis Meets Primary Goal

NEW BRUNSWICK (dpa-AFX) - Idorsia Ltd said that the Janssen Pharmaceutical Companies of Johnson & Joh... See more »
June 5, 2019Business Medical Dialogues

Swiss company Actelion moves US court against Natco Pharma over generic of its patented drug

Hyderabad: Swiss pharma company Actelion Pharmaceuticals Ltd has filed a petition in a US court alleg... See more »
June 5, 2019Business Medical Dialogues

Natco Pharma files ANDA for generic version of Bosentan tablets for oral suspension

Bosentan 32 mg tablets are sold by Actelion Pharmaceuticals US, Inc. (acquired by Johnson and Johnson... See more »
May 22, 2019Pharmabiz

Owlstone Medical inks pact with Actelion to develop breath─based test to help facilitate early detection of pulmonary hypertension

Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and ... See more »
March 27, 2019BioPortfolio

Third Pole Therapeutics announces inhaled nitric oxide strategic collaboration with Actelion

The collaboration will bring the global resources and knowhow of the largest and most respected healt... See more »

Actelion Press Releases

September 18, 2018Social Media Portal

Actelion's Pieter De Muynck on the forthcoming Marketing & CX Pharm

Learn what to expect from Actelion & Marketing and CX in the Pharmaceutical Industry Conference with ... See more »
February 6, 2018GlobeNewswire

Idorsia announces financial results for 2017 - company off to a great start - 4 compounds to enter Phase 3 development

Allschwil, Switzerland - 06 February 2018 - Idorsia Ltd (SIX: IDIA) today announced its financial res... See more »
May 14, 2017GlobeNewswire

Actelion announces changes to its executive team upon completion of the transaction with Johnson & Johnson

See more »
February 7, 2017Business Wire

Gaucher Disease - Pipeline Review, H2 2016 - Therapeutics Assessment by Drug Target, MoA, RoA & Molecule Type - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Gaucher Disease - Pi... See more »
January 26, 2017GlobalNewswire

Press Release German

See more »
January 26, 2017GlobeNewswire

Press Release German

See more »
December 27, 2016PressReleasePing

Actelion Ltd - Strategy, SWOT and Corporate Finance Report

Actelion Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data... See more »

Social Statistics

Headquarters

Gewerbestrasse 16

Allschwil, Basel-Country4123

41-61-565-6565

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Actelion is a bio-technology firm that discovers, develops and commercializes drugs for unmet medical needs. Actelion was founded in 1997. Actelion's headquarters is located in Allschwil, Basel-Country, CH 4123. Actelion's latest acquisition was .Acte...

Website

actelion.com

Frequently Asked Questions about Actelion

  1. When was Actelion founded?

    Actelion was founded in 1997

  2. How much revenue does Actelion generate?

    Actelion generates $2.4B in revenue

  3. How much funding does Actelion have?

    Actelion has historically raised $0 in funding

  4. Where is Actelion's headquarters?

    Actelion's headquarters is in Allschwil Basel-Country, CH

  1. How many employees does Actelion have?

    Actelion has 2,421 employees

  2. What sector does Actelion operate in?

    Actelion is in Pharmaceuticals

  3. Who are Actelion's competitors?

    Actelion's top competitors are Gilead, Genentech, Amgen
Stay up-to-date with the latest news on Actelion